UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of ~~September~~December 2024

Commission File Number: 001-39316

BURNING ROCK BIOTECH LIMITED

(Registrant’s Name)

No.5 Xingdao Ring Road North, International Bio Island

Guangzhou, Guangdong

People’s Republic of China

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

~~Incorporation~~EXHIBIT byINDEX ~~Reference~~

This Report on Form 6-K (the “Report”) shall be deemed to be incorporated by reference into the registration statements on Form F-3 (File No. 333-264577) and Form S-8 (File No. 333-251191) of Burning Rock Biotech Limited (the “Company”) (including any prospectuses forming a part of such registration statements) and to be a part thereof from the date on which this Report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.


Number		Description of Document

99.1		Press release

99.2		Notice of Annual General Meeting

99.3		Form of Proxy for the Annual General Meeting

99.4		Form of Voting Card for ADS Holders

Exhibit Index

Number		Description of Document
Exhibit 99.1		Press release

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Burning Rock Biotech Limited By: /s/ Yusheng Han Name: Yusheng Han Title: Chief Executive Officer


	Burning Rock Biotech Limited

	By:	/s/ Yusheng Han
	Name:	Yusheng Han
	Title:	Chief Executive Officer

Date: December 3, 2024

Date: September 27, 2024

Filing Compare · Burning Rock Biotech Ltd